Pharmacokinetics metabolic reactions

When evaluating the safety of chemicals in humans, it is very important to know the fate of chemicals in the human body and the amounts of exposure in daily activity. This section reviews the metabolic reactions of pyrethroids in humans, and the biomonitoring of pyrethroid metabolites in human urine for the exposure assessment. Mathematical modeling is a useful tool to predict the fate of chemicals in humans. This section also deals with the recent advance of mathematical modeling of pyrethroids to predict the pharmacokinetics of pyrethroids. 

The pharmacokinetic implications of these findings are not straightforward. One important factor that must also be considered is hepatic extraction, which is higher for lovastatin than for its hydroxy acid metabolite [188], Some lactones are useful prodrugs of HMG-CoA reductase inhibitors due to this organ selectivity coupled with the efficiency of enzymatic hydrolysis. However, other factors may also influence the therapeutic response, in particular the extent and rate of metabolic reactions that compete with or follow hydrolysis, e.g., cytochrome P450 catalyzed oxidations, /3-oxidation, and tau-... 

This approach has the possible advantage over using a combination of two inhibitors, that it eliminates all the pharmacokinetic variables and synchronizes the inhibitory action at the two enzyme sites. However, there is a competition between the two enzymes for the inhibitor, since each molecule of the latter can bind only to one enzyme therefore, the relative extent of inhibition of the two metabolic reaction steps depends on the relative affinities (ratio of the Kj values) of the inhibitor for the two enzymes. This, of course, is determined by the structure of the inhibitor, and it should be amenable to change via structural modifications (e.g., by providing 71 with a hydroxyalkyl side chain and thus making it more closely similar in structure to riboflavin and more antagonistic to it). Although this approach has inherent limitations in scope, its further exploration appears to be of interest. 

This pathway is discussed in Section 7.5 Pharmacokinetics. However, we first need to discuss enzymes and enzyme kinetics, which we wit) do in Section 7.2. Check the CD-ROM and the web for future updates on metabolic reaction,... 

Beach JW. Chemotherapeutic agents for human immunodeficiency virus infection mechanism of action, pharmacokinetics, metabolism, and adverse reactions. Clin Ther 1998 20 2-25. 

LC-MS IN DRUG METABOLISM AND PHARMACOKINETICS A PHARMACEUTICAL INDUSTRY PERSPECTIVE TABLE 6.7 Metabolic Reactions that Lead to Metabolites Significantly Smaller Than the Parent Drngs [159]... 

A second area of drug discovery and development in which enzyme reactions play a critical role is in the study of drug metabolism and pharmacokinetics. The elimination of xenobiotics, including drug molecules, from systemic circulation is driven by metabolic transformations that are entirely catalyzed by enzymes. Table 1.2 lists some of the enzyme-catalyzed transformations of xenobiotics that commonly contribute to drug molecule elimination. These biotransformation reactions... 

The development of synthetic methods for the selective introduction of short-chain perfluoroalkyl groups into organic molecules is of interest in drug development [464]. Fluoromodifications often confer unique properties on a molecule, for example in terms of increased metabolic stability and lipophilicity and, as a consequence, the pharmacokinetic profiles are often improved [465]. Burger and coworkers developed a domino process consisting of a SN reaction combined with a Claisen and a Cope rearrangement which allows the transformation of simple fluorinated compounds into more complex molecules with fluoro atoms [466]. Treatment of furan 2-917 with 2-hydroxymethyl thiophene (2-918) in the presence... 

In summary, (oxodioxolyl)methyl esters of carboxylic acid drugs appear to be generally useful as prodrugs. However, more studies are needed to document the structure-metabolism relationships, the relative contribution of enzymatic vs. nonenzymatic reactions in their in vivo activation, the reasons of some failures, their toxic potential, and their pharmacokinetic behavior in humans. 

---